Triazolopyrazine
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceu...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament. |
---|---|
AbstractList | The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament. |
Author | GIANNI, DAVIDE SMETHURST, CHRISTIAN ENGELHARDT, HARALD |
Author_xml | – fullname: SMETHURST, CHRISTIAN – fullname: ENGELHARDT, HARALD – fullname: GIANNI, DAVIDE |
BookMark | eNrjYmDJy89L5WQQCCnKTKzKz8kvqCxKrMrMS-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGhibGJhbGFo7GxKgBAKBFIbE |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | TW201434838A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_TW201434838A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:53:38 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_TW201434838A3 |
Notes | Application Number: TW20132141767 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&CC=TW&NR=201434838A |
ParticipantIDs | epo_espacenet_TW201434838A |
PublicationCentury | 2000 |
PublicationDate | 20140916 |
PublicationDateYYYYMMDD | 2014-09-16 |
PublicationDate_xml | – month: 09 year: 2014 text: 20140916 day: 16 |
PublicationDecade | 2010 |
PublicationYear | 2014 |
RelatedCompanies | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
RelatedCompanies_xml | – name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
Score | 3.06484 |
Snippet | The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification.... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Triazolopyrazine |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&locale=&CC=TW&NR=201434838A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5MSzJJNTLWNQdWbromicnAPJdilqSblmgCbL-mGqdagjfS-vqZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YdHqToZmai5Ota4C_i7-zmrOzbUi4ml8QWM7YxMLYwpGZgRXYjDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwCIcC0UgUsqwoqi8BnQosyKLq5hjh76AKNjof7Iz4kHOEKYzEGFmD_PlWCQSHJNDHVMBnYOzQ2SDNJSk5MSrZIMjOySDIyBlbuqcnGkgxSuM2RwicpzcAF4oCWNxiayTCwlBSVpsoC69CSJDmw5wGrnHVQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5MSzJJNTLWNQdWbromicnAPJdilqSblmgCbL-mGqdagjfS-vqZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YdHqToZmai5Ota4C_i7-zmrOzbUi4ml8QWM7YxMLYwpGZgRXYxDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwCIcC0UgUsqwoqi8BnQosyKLq5hjh76AKNjof7Iz4kHOEKYzEGFmD_PlWCQSHJNDHVMBnYOzQ2SDNJSk5MSrZIMjOySDIyBlbuqcnGkgxSuM2Rwicpz8DpEeLrE-_j6ectzcAFkgAtdTA0k2FgKSkqTZUF1qclSXLggAAAVdV4Qw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Triazolopyrazine&rft.inventor=SMETHURST%2C+CHRISTIAN&rft.inventor=ENGELHARDT%2C+HARALD&rft.inventor=GIANNI%2C+DAVIDE&rft.date=2014-09-16&rft.externalDBID=A&rft.externalDocID=TW201434838A |